STAAR Surgical (STAA)
(Delayed Data from NSDQ)
$47.82 USD
-0.37 (-0.77%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $47.79 -0.03 (-0.06%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Income Statements
Fiscal Year end for STAAR Surgical Company falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 322 | 284 | 230 | 163 | 150 |
Cost Of Goods | 70 | 61 | 52 | 45 | 38 |
Gross Profit | 253 | 223 | 179 | 118 | 112 |
Selling & Adminstrative & Depr. & Amort Expenses | 225 | 180 | 145 | 112 | 100 |
Income After Depreciation & Amortization | 28 | 44 | 33 | 7 | 12 |
Non-Operating Income | 6 | 2 | -2 | 2 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 34 | 46 | 31 | 8 | 13 |
Income Taxes | 12 | 7 | 7 | 2 | -1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 21 | 39 | 25 | 6 | 14 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 21 | 39 | 25 | 6 | 14 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 31 | 47 | 37 | 10 | 16 |
Depreciation & Amortization (Cash Flow) | 3 | 3 | 4 | 3 | 4 |
Income After Depreciation & Amortization | 28 | 44 | 33 | 7 | 12 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 49.43 | 49.38 | 49.46 | 47.95 | 46.90 |
Diluted EPS Before Non-Recurring Items | 0.67 | 0.81 | 0.58 | 0.35 | 0.46 |
Diluted Net EPS (GAAP) | 0.43 | 0.78 | 0.50 | 0.12 | 0.30 |
Fiscal Year end for STAAR Surgical Company falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 76.27 | 80.31 | 92.31 | 73.53 |
Cost Of Goods | NA | 15.55 | 16.67 | 21.58 | 15.97 |
Gross Profit | NA | 60.73 | 63.64 | 70.73 | 57.56 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 50.32 | 57.34 | 62.13 | 54.76 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 10.41 | 6.30 | 8.60 | 2.80 |
Non-Operating Income | NA | 3.33 | 0.45 | -0.11 | 1.92 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 13.74 | 6.75 | 8.49 | 4.72 |
Income Taxes | NA | 5.98 | 1.93 | 2.43 | 2.01 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 7.76 | 4.82 | 6.06 | 2.71 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 7.76 | 4.82 | 6.06 | 2.71 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 49.24 | 49.37 | 49.52 | 49.50 |
Diluted EPS Before Non-Recurring Items | NA | 0.24 | 0.13 | 0.23 | 0.05 |
Diluted Net EPS (GAAP) | NA | 0.16 | 0.10 | 0.12 | 0.05 |